Related Experiment Videos

Parkinson's disease mortality among male anesthesiologists and internists

Chava Peretz1, Bruce H Alexander, Sonia I Nagahama

  • 1Sackler Faculty of Medicine, School of Health Professionals, Tel Aviv University, Tel Aviv, Israel.

Insights

Parkinson's disease (PD) mortality was studied in anesthesiologists and internists. Anesthesiologists showed higher PD mortality, suggesting potential links to infectious agents or anesthetic gases.

Area of Science:

  • Neurology
  • Epidemiology
  • Occupational Health

Background:

  • Clusters of Parkinson's disease (PD) suggest infectious causes.
  • Anesthetic gases are linked to parkinsonism and PD in patients.

Purpose of the Study:

  • Investigate PD mortality in male U.S. anesthesiologists and internal medicine physicians.
  • Examine the association between anesthetic exposure and PD risk.

Main Methods:

  • Compared PD mortality rates between large cohorts of anesthesiologists (n=33,040) and internists (n=33,044).
  • Analyzed PD mortality from death certificates for underlying cause and any mention.

Main Results:

  • Overall PD mortality was lower than U.S. men for both groups (1979-1995).
  • Anesthesiologists had significantly elevated PD mortality as underlying cause for 10-year follow-up.
  • Excess PD mortality (any mention and underlying cause) observed in anesthesiologists for >10-year follow-up.

Conclusions:

  • Findings support the hypothesis linking infectious agents or anesthetic gases to PD etiology.
  • Occupational exposure in anesthesiology may increase Parkinson's disease risk.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...